Pfizer has joined the ranks of companies developing cancer drugs that target both PD-1 and VEGF – one of the hottest drug classes in oncology, via a $6 billion licensing deal with China's 3SBio.

Wilson Borough Council approved a tax abatement program for its portion of the land where a million-square-foot warehouse is proposed near Route 22.